Clinical studies recruiting near Limoges

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt · Pfizer · NCT05020236 Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Phase 2 · Chu Dupuytren- Limoges · Institut Curie · NCT07193394 Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
NA · Centre d'Investigation Clinique · University Hospital, Limoges · NCT06853886 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · CHU De LIMOGES · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Limoges · University Hospital, Limoges · NCT04592003 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Limoges University Hospital · Poitiers University Hospital · NCT05686850 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service de thérapie cellulaire et l'hématologie clinique adu · University Hospital, Clermont-Ferrand · NCT04935684 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Service Hématologie Clinique et Thérapie Cellulaire, CHU DE · Hospices Civils de Lyon · NCT05444712 Integrating AI in Stroke Neurorehabilitation
NA · CHU de Limoges · Eodyne Systems SL · NCT07138495 Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer
NA · University Hospital, Limoges · Medical University of Gdansk · NCT07669298 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Gra
Phase 2 · CHU Dupuytren · Centre Leon Berard · NCT03624244 Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More
Phase 2 · CHU Limoges · Assistance Publique - Hôpitaux de Paris · NCT06646497 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · CHU Limoges - Site Dupuytren · Assistance Publique - Hôpitaux de Paris · NCT05387954 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Centre Hospitalier Universitaire (Limoges) (CHU DUPUYTREN 1) · Loxo Oncology, Inc. · NCT05254743 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt · Celgene · NCT05519085 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · CHU Dupuytren · Federation Francophone de Cancerologie Digestive · NCT07270991 Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Phase N/A · CHU Limoges · Gérond'if · NCT06427304 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · Chu Dupuytren · Centre Leon Berard · NCT06393816 A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years)
Phase 2 · Chu de Limoges · Institut Claudius Regaud · NCT06022159 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · Chu Limoges · University Hospital, Lille · NCT05572229 Dat'Aids Prevention
Phase N/A · CHU Limoges · DatAids · NCT03795376 Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
Phase N/A · C H U DE LIMOGES- Hopital Dupuytren · Acute Leukemia French Association · NCT04777916 Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis
NA · CHU Limoges · University Hospital, Rouen · NCT04604730 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · CHU Limoges Service de Nephrology · Takeda · NCT06963827 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Polyclinique de Limoges - Francois Chenieux · Janssen Research & Development, LLC · NCT06319820 Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · Department of Nephrology, University Hospital of Limoges · University Hospital, Tours · NCT05732727 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · Centre Hospitalier Universitaire Limoges · Taiho Oncology, Inc. · NCT05967689 Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · CHU de Limoges · UNICANCER · NCT07661927 Epidemiological Data on Mast Cell Pathologies in France
Phase N/A · Chu - Limoges · Imagine Institute · NCT06186856

Look up another city

Look up another condition